Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Personalis, Inc. - Common Stock (NQ:PSNL)

6.530 +0.300 (+4.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,288,005
Open 6.260
Bid (Size) 6.500 (2)
Ask (Size) 6.670 (1)
Prev. Close 6.230
Today's Range 6.060 - 6.710
52wk Range 1.135 - 7.200
Shares Outstanding 48,518,901
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO
From Personalis, Inc.
Via Business Wire
New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse
From Personalis, Inc.
Via Business Wire

Performance

YTD
+4.1%
+4.1%
1 Month
+30.1%
+30.1%
3 Month
+77.9%
+77.9%
6 Month
+83.4%
+83.4%
1 Year
+418.3%
+418.3%

More News

Read More
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection
From Personalis, Inc.
Via Business Wire
Earnings Scheduled For May 6, 2025
Via Benzinga
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts
Via Benzinga
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
From Personalis, Inc.
Via Business Wire
Analyst Expectations For Personalis's Future
Via Benzinga
Personalis Reports First Quarter 2025 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
From Personalis, Inc.
Via Business Wire
Earnings Scheduled For February 27, 2025
Via Benzinga
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Personalis to Announce First Quarter 2025 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
From Personalis, Inc.
Via Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Via Investor's Business Daily
What 5 Analyst Ratings Have To Say About Personalis
Via Benzinga
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
From Personalis, Inc.
Via Business Wire
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Via Benzinga
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip
Via Benzinga
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
From Personalis, Inc.
Via Business Wire
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
From Personalis, Inc.
Via Business Wire
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
Via Benzinga
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
From Personalis, Inc.
Via Business Wire
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From Personalis, Inc.
Via Business Wire
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer
From Personalis, Inc.
Via Business Wire

Frequently Asked Questions

Is Personalis, Inc. - Common Stock publicly traded?
Yes, Personalis, Inc. - Common Stock is publicly traded.
What exchange does Personalis, Inc. - Common Stock trade on?
Personalis, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Personalis, Inc. - Common Stock?
The ticker symbol for Personalis, Inc. - Common Stock is PSNL on the Nasdaq Stock Market
What is the current price of Personalis, Inc. - Common Stock?
The current price of Personalis, Inc. - Common Stock is 6.530
When was Personalis, Inc. - Common Stock last traded?
The last trade of Personalis, Inc. - Common Stock was at 06/18/25 04:00 PM ET
What is the market capitalization of Personalis, Inc. - Common Stock?
The market capitalization of Personalis, Inc. - Common Stock is 316.83M
How many shares of Personalis, Inc. - Common Stock are outstanding?
Personalis, Inc. - Common Stock has 317M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.